TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 54 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $315,000 | +2150.0% | 67,976 | +3606.4% | 0.00% | – |
| Q3 2015 | $14,000 | -99.3% | 1,834 | -95.7% | 0.00% | -100.0% |
| Q2 2015 | $2,037,000 | -12.9% | 42,937 | -32.7% | 0.00% | -25.0% |
| Q1 2015 | $2,339,000 | -32.6% | 63,831 | -26.5% | 0.00% | -33.3% |
| Q4 2014 | $3,472,000 | +58.4% | 86,811 | -21.0% | 0.01% | +50.0% |
| Q3 2014 | $2,192,000 | +219100.0% | 109,896 | +174338.1% | 0.00% | – |
| Q3 2013 | $1,000 | – | 63 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |